Answers are grounded in this paper and cite their sources.
Designing patient-specific follow-up strategies is key to personalized cancer care. Tools to assist doctors in treatment decisions and scheduling follow-ups based on patient preferences and medical data would be highly beneficial. These tools should incorporate realistic models of disease progression under treatment, multi-objective optimization of treatment strategies, and efficient algorithms to personalize follow-ups by considering patient history. We propose modeling cancer evolution using a Piecewise Deterministic Markov Process, where patients alternate between remission and relapse phases, and control the model via long-term cost function optimization. This considers treatment side effects, visit burden, and quality of life, using noisy blood marker measurements for feedback. Instead of discretizing the problem with a discrete Markov Decision Process, we apply the Partially-Observed Monte-Carlo Planning algorithm to solve the continuous-time, continuous-state problem, leveraging the near-deterministic nature of cancer progression. Our approach, tested on multiple myeloma patient data, outperforms exact solutions of the discrete model and allows greater flexibility in cost function modeling, enabling patient-specific follow-ups. This method can also be adapted to other diseases.
No takes yet. Share an insight, caveat, or question.
Saporta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: